Abstract:Although megakaryocytic and erythroid maturation have been studied, little is known about the molecular mechanisms underlying megakaryocytic-erythroid progenitor (MEP) fate specification. Addressing this question, I proposed to perform a CRISPR screen to interrogate a panel of genes for their ability to regulate MEP fate. As primary human cell numbers are limited, the number of genes to be analyzed is ∼80 to allow 3 gRNAs per gene with at least 50 cells per gRNA and estimating a transduction efficiency of ∼30% to assure 1 gRNA per cell (1 gene per 450 cells). For this screen, I am optimizing the use of guide swap (Ting et al., 2018), that allows primary cell editing by transducing cells with a library of gRNAs using lentivirus followed by transfection with Cas9 protein precomplexed to nontargeting gRNA (ntRNA). Once inside a cell, the gRNA ‘swaps’ with the ntRNA to efficiently edit the cell. I am using CROPseq (Datlinger et al., 2017) vector with an mCherry fluorescent reporter that allows the gRNA sequence within a transduced cell to be detected along with the total RNA by scRNAseq. Transfection of progenitors with a CD45-targeting single guide RNA (sgRNA) precomplexed with Cas9-GFP yields ∼38% CD45 negative cells within 4 days. Simultaneously, lentiviral transduction using the mCherry fluorescent reporter was performed. We found that pretreatment with AZD7648, a DNA-PK inhibitor, enhances CRISPR-induced modification. Using our optimized approaches AZD7648 pretreatment enhanced post-transfection CD45 negative cells from 17% using Cas9 alone to 30%. A small library (5 nontargeting, 3 positive controls and 5 interrogated genes) has been cloned into the CROPseq-mCherry vector resulting equal guide representations. Thus, I am progressing in a stepwise manner towards the goal of performing a larger scale screen of genes that regulate MEP fate specification.

A novel screening system based on gene targeting to enrich the modified mammalian cells: without leaving selection marker and additional sequence

Efficient CRISPR/Cas9-mediated gene editing in mammalian cells by the novel selectable traffic light reporters

Advantages of q-PCR as a method of screening for gene targeting in mammalian cells using conventional and whole BAC-based constructs

Towards Genetic Genome Projects: Genomic Library Screening and Gene-Targeting Vector Construction in a Single Step

Efficient gene editing through an intronic selection marker in cells

An efficient Screening System in Yeast to Select a Hyperactive piggyBac Transposase for Mammalian Applications

Design Principles of a Novel Construct for HBB Gene-Editing and Investigation of Its Gene-Targeting Efficiency in HEK293 Cells

A highly efficient transgene knock-in technology in clinically relevant cell types

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

Development of a universal antibiotic resistance screening system for efficient enrichment of C-to-G and A-to-G base editing

A novel sgRNA selection system for CRISPR-Cas9 in mammalian cells

Rapid generation of homozygous fluorescent knock-in human cells using CRISPR–Cas9 genome editing and validation by automated imaging and digital PCR screening

An Enhanced Retroviral Vector for Efficient Genetic Manipulation and Selection in Mammalian Cells

High-content imaging-based pooled CRISPR screens in mammalian cells

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

Construction of a Mouse Novel Gene Targeting Vector and Recombination Screening

Recent advances in targeted genome engineering in mammalian systems.

GENE-10. A SIMPLE AND EFFICIENT METHOD FOR GENERATING MULTI-ALLELIC INSERTION-DELETION MUTATIONS AND PRECISE DELETIONS IN PRIMARY HUMAN CELL CULTURES

3092 – CRISPR OPTIMIZATION TO SCREEN FOR GENES THAT REGULATE FATE SPECIFICATION OF PRIMARY HUMAN HEMATOPOIETIC PROGENITORS

Construction of Conveniently Screening Plko.1-Trc Vector Tagged with Turbogfp

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening